CoreBone

Developer of a bioactive, coral-based bone graft material for dental and orthopedic treatments.

Health Tech & Life Sciences
Active
Series A Misgav, Israel Founded 2011
Last updated 2026-07-23
Total raised
$6.3M
Last: Undisclosed Round 2021-10
Stage
Series A
Founded
2011
Headcount
6
HQ
Misgav, Israel
Sector
Health Tech & Life Sciences

About

CoreBone is an Israeli company that develops and distributes bioactive, coral-based bone graft material for dental and orthopedic indications. The company utilizes a proprietary technology to grow corals in a controlled aquatic system, enriching them with bioactive minerals to create a bone substitute with high integration ability. CoreBone's products offer a natural alternative to synthetic, human, or animal-derived bone graft materials, eliminating risks of disease transfer. They are also developing CoreTlage, a cartilage regeneration platform. CoreBone's coral bone grafts have been commercially available in selected markets since 2017, with thousands of successful procedures. CoreBone has been awarded CE approval, and FDA 510K submission is planned for mid-2017.

Funding history · 3 rounds · $6.3M total

2021-09
A Round $3.7M
★ Guangzhou Sino-Israel Biotech Investment Fund (GIBF)Agriline
2018-01
Seed Extension $617K
★ ExitValley
2012-12
Seed $2.0M

Headcount over time

From 4 (2018-09) to 6 (2026-03) · +2 (+50%) · 7 points · source: Finder history + radar grounding
60 2018-09 2026-03

Q&A

What is CoreBone's primary product?
CoreBone has developed a strong, bioactive coral bone graft for dental and orthopedic indications. This biomimetic bone graft offers bonelike qualities without being derived from human or animal bone.
When was CoreBone founded?
CoreBone was founded in December 2011.
What is CoreBone's total funding to date?
CoreBone has raised a total of $6,317,000 across its funding rounds.
When was CoreBone's most recent funding round and who were the lead investors?
CoreBone's most recent funding round occurred in October 2021, with Guangzhou Sino-Israel Biotech Investment Fund (GIBF) as a lead investor.
Who are the co-founders of CoreBone?
The co-founders of CoreBone are Ohad Schwartz and Prof. Itzhak Binderman.
What certifications does CoreBone hold for its products?
CoreBone products are CE and ISO 13485 certified.
What is CoreBone's primary sector?
CoreBone's primary sector is Health Tech & Life Sciences.

Team · 2

Itzhak Binderman
Founder · Co-Founder & CTO
Ohad Schwartz
Founder · Co-Founder & CEO

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue Engineering
Technologies
Materials & SubstancesBiologicals
Target customers
Commerce & RetailDistribution ChannelsDistributorHealthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 Patents

Tags

biotechnologymedical-technologiesdentalorthopedicsbone
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitecore-bone.com
LinkedInlinkedin.com/company/17882021

Identifiers & details

Founded2011-12
Employees (exact)6

Radar intelligence

Patents

EPO9

Web history (Wayback)

Domaincore-bone.com

Certificate / subdomain footprint

Subdomains1

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)514687151
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2011-11-08
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2024
Active charges / liens0
Registry events1 — violation (1)
Registered address17 משגב

Recent registry events

DateEvent
2026-05-27עדכון הפרה